Ivan Lechner
@lechner_i
Resident at University Clinic for Internal Medicine III, Cardiology & Angiology, Innsbruck, Austria
ID: 141380192
https://orcid.org/0000-0003-1379-3233 07-05-2010 23:23:45
136 Tweet
89 Followers
138 Following
#TAVR-CMR trial presented by Martin Reindl in late-breaking science on imaging #ESCCongress2023 #whyCMR Check it out: ahajournals.org/doi/10.1161/CI… Sebastian J Reinstadler Ivan Lechner Magdalena Holzknecht CoT Austria @imed_tweets
It is a great pleasure to post our simultaneous publication at #ESCCongress: The randomized TAVR CMR trial now online at Circulation demonstartes the NI of #whyCMR TAVR guidance vs. CT guidance. @imed_tweets Ivan Lechner Magdalena Holzknecht Christina Tiller see at: ahajournals.org/doi/10.1161/CI…
Infarct severity and outcomes in #STEMI without standard modifiable risk factors (#SMuRFless) – A multicenter #whyCMR study! @imed_tweets Ivan Lechner Magdalena Holzknecht Christina Tiller Colin Berry Robin Nijveldt Holger Thiele Ingo Eitel Hans-Josef Feistritzer EACVI President sciencedirect.com/science/articl…
All credit to the patients and staff who supported our British Heart Foundation #CorCTA study ahajournals.org/doi/10.1161/CI…
This week on Circulation on the run we discussed, together with Victoria Delgado, our trial "CMR vs CT to Guide TAVR-CMR: A Randomized, Open-Label, Non-Inferiority Trial." Check out: Circulation October 17, 2023 Issue circulation.libsyn.com/circulation-oc…
Dysglycaemia and Persistent Infarct Core Iron in #STEMI sciencedirect.com/science/articl… @imed_tweets Ivan Lechner #whyCMR
Comprehensive characterization of myocardial tissue by cardiac magnetic resonance imaging reveals no association between culprit lesion vessel size and reperfusion injury in #STEMI. Read more in our latest article published in #JAHA #whyCMR Sebastian J Reinstadler @imed_tweets
Culprit lesion vessel size is not a factor in myocardial tissue reperfusion failure in #STEMI: findings from a cardiac magnetic resonance imaging study. #AHAJournals Ivan Lechner Sebastian J Reinstadler @imed_tweets ahajrnls.org/49s0IgW
🧲💟New Journal of CMR study by Ivan Lechner, Sebastian J Reinstadler and co-authors reveals ongoing dysglycemia linked to persistent infarct core iron in STEMI patients post-PCI, highlighting HbA1c's predictive value. Pdf via this link 👉 journalofcmr.com/article/S1097-… brief explanation 👇
Our most recent publication on the relation of plasma neuropeptide-Y with infarct severity after #STEMI Check out here: sciencedirect.com/science/articl… Christina Tiller Magdalena Holzknecht @imed_tweets Ivan Lechner #whyCMR
Our #whyCMR paper in JACC Journals shows that reperfused STEMI with intramyocardial hemorrhage (IMH) have a much higher risk of MACE than STEMI with MVO but not IMH. IMH=key culprit driving MACE post-MI. Ivan Lechner @imed_tweets jacc.org/doi/10.1016/j.…
Our latest editorial is now available Temporal trends in #ACS outcomes: Balancing technological advances with patient complexity sciencedirect.com/science/articl… Ivan Lechner @imed_tweets International Journal of Cardiology
Check out our recently published study about the relationship between PCSK9 and reperfusion injury in revascularized #STEMI. #whyCMR CircImaging Sebastian J Reinstadler Magdalena Holzknecht Ivan Lechner @imed_tweets More info’s: lnkd.in/eQhEWxJG